Mannik M, David K A, Gauthier V J
J Immunol. 1981 Nov;127(5):1993-9.
Human serum albumin (HSA) was conjugated with 4-fluoro-3-nitrophenyl azide to yield varying density of the 4-azido-2-nitrophenyl haptenic group, useful for covalent cross-linking in the antibody-combining site. The epitope density of the antigen influenced several examined biologic properties. Precipitation in gel diffusion occurred when the average epitope density was 13 or above. Complement (C) activation was not found by incubation with guinea pig C, by binding to human Clq, or by conversion of the electrophoretic mobility of human C3 with epitope densities up to 13. Upon i.v. injection, rapid removal of the conjugated HSA occurred when more than seven 4-azido-2-nitrophenyl groups were present. This rapid removal was in part due to hepatic uptake. These studies point out the epitope density-dependent alterations of biologic properties of an antigen useful for preparation of immune complexes covalently cross-linked in the antibody-combining site.
人血清白蛋白(HSA)与4-氟-3-硝基苯叠氮化物偶联,以产生不同密度的4-叠氮基-2-硝基苯基半抗原基团,该基团可用于在抗体结合位点进行共价交联。抗原的表位密度影响了几种被检测的生物学特性。当平均表位密度为13或更高时,在凝胶扩散中会发生沉淀。通过与豚鼠补体(C)孵育、与人C1q结合或用表位密度高达13的人C3进行电泳迁移率转换,均未发现补体激活。静脉注射时,当存在超过七个4-叠氮基-2-硝基苯基基团时,偶联的HSA会迅速被清除。这种快速清除部分归因于肝脏摄取。这些研究指出了抗原生物学特性的表位密度依赖性改变,这对于制备在抗体结合位点共价交联的免疫复合物很有用。